These findings are further supported by a report demonstrating epigenetic suppression of ASPP2 expression by gDNA methylation as suggested in hepatitis B-associated hepatocellular carcinoma[37]. This evidence concerns the gene TP53BP2 and hepatocellular carcinoma.